1. Home
  2. BCX vs AMPH Comparison

BCX vs AMPH Comparison

Compare BCX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Resources of Beneficial Interest

BCX

BlackRock Resources of Beneficial Interest

HOLD

Current Price

$12.88

Market Cap

898.8M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$23.59

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCX
AMPH
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.8M
885.4M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BCX
AMPH
Price
$12.88
$23.59
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$28.38
AVG Volume (30 Days)
146.2K
326.4K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
6.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.81
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
N/A
$4.64
P/E Ratio
N/A
$28.44
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$16.65
52 Week High
$13.86
$29.52

Technical Indicators

Market Signals
Indicator
BCX
AMPH
Relative Strength Index (RSI) 55.39 66.77
Support Level $11.90 $18.36
Resistance Level $13.05 $24.35
Average True Range (ATR) 0.21 0.69
MACD -0.05 0.06
Stochastic Oscillator 15.81 81.95

Price Performance

Historical Comparison
BCX
AMPH

About BCX BlackRock Resources of Beneficial Interest

BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies, or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: